CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL
- 专利权人:
- IDORSIA PHARMACEUTICALS LTD
- 发明人:
- Cyrille LESCOP
- 申请号：
- US16503245
- 公开号：
- US20190322657A1
- 申请日:
- 2019.07.03
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- The present invention relates to a crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
- S-3-4-[5-2--6---4--[124]-3-]-2--6----12- CRYSTALLINE FORM OF THE COMPOUND S-3-4-[5-2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL-[124]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY-PROPANE-12-DIOL
- 結晶形式
- S-3-4-[5-2--6---4--[124]-3-]-2--6----12- CRYSTALLINE FORM OF THE COMPOUND S-3-4-[5-2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL-[124]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY-PROPANE-12-DIOL
- Compound (S) -3- {4- [5- (2-Cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4] oxadiazol-3-yl] -2-ethyl-6 -Methyl-phenoxy} -propane-1,2-diol crystal form
